Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pliant Therapeutics (PLRX)
NASDAQ:PLRX
Pliant Therapeutics (PLRX) Stock Forecast & Price Target
357 Followers
See the Price Targets and Ratings of:
PLRX Analyst Ratings
Strong Buy
11 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PLRX Stock 12 Month Forecast
Average Price Target
$41.88
▲(298.10% Upside)
| Highest Price Target$48.00 | Average Price Target$41.88 | Lowest Price Target$36.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
H.C. Wainwright
Reiterated
06/07/24
Leerink Partners
Reiterated
05/14/24
Canaccord Genuity
Reiterated
05/14/24
Stifel Nicolaus
Reiterated
05/14/24
Needham
$38
Buy
261.22%
Upside
Reiterated
05/07/24
Optimistic Buy Rating for Pliant Therapeutics Amidst Strong Pipeline Progress and Potential Breakthroughs
BTIG
$33
Buy
213.69%
Upside
Reiterated
02/28/24
Buy Rating Affirmed for Pliant Therapeutics Amid Promising Drug Pipeline and Financial Stability
J.P. Morgan
$48→$47
Buy
346.77%
Upside
Reiterated
11/10/23
Pliant Therapeutics (PLRX) PT Lowered to $47 at JPMorganJPMorgan analyst Eric Joseph lowered the price target on Pliant Therapeutics (NASDAQ: PLRX) to $47.00 (from $48.00) while maintaining a Overweight rating.
Robert W. Baird
$44
Buy
318.25%
Upside
Reiterated
09/26/23
Analysts Are Bullish on These Healthcare Stocks: Karyopharm Therapeutics (KPTI), Pliant Therapeutics (PLRX)
Best Analysts Covering Pliant Therapeutics
Which Analyst Should I Follow If I Want to Buy PLRX and Sell After:
1 Month
3 Months
1 Year
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PLRX Analyst Recommendation Trends
Rating
Feb 24
Mar 24
Apr 24
May 24
Jun 24
Strong Buy
31
22
22
21
19
Buy
3
3
3
4
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
34
25
25
25
22
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
PLRX Financial Forecast
PLRX Stock Forecast FAQ
What is PLRX’s average 12-month price target, according to analysts?
Based on analyst ratings, Pliant Therapeutics’s 12-month average price target is $41.88.
What is PLRX’s upside potential, based on the analysts’ average price target?
Pliant Therapeutics has 298.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PLRX a Buy, Sell or Hold?
Pliant Therapeutics has a consensus rating of Strong Buy which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.
What is Pliant Therapeutics’s price target?
The average price target for Pliant Therapeutics is $41.88. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $48.00 ,the lowest forecast is $36.00. The average price target represents 298.10% Increase from the current price of $10.52.
The highest analyst price target is $48.00 ,the lowest forecast is $36.00. The average price target represents 298.10% Increase from the current price of $10.52.
What do analysts say about Pliant Therapeutics?
Pliant Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of PLRX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.